GABARAP and osteosarcoma: These findings collectively underscored the dual role of GABARAP in promoting osteosarcoma progression through metabolic reprogramming and immune evasion mechanisms, as evidenced by its spatial association with critical metabolic pathways and immunosuppressive TME features.